Equity strategies

Carmignac Portfolio Emergents

Emerging marketsSRI Fund Article 9
Share Class

LU1299303229

Grasping the most promising opportunities within the emerging universe
  • A concentrated and high conviction portfolio seeking high alpha generation across the diversified emerging market universe.
  • A Fund focused on selecting high-quality companies that offer attractive long-term growth prospects, with sound financials and sustainable profitability.
Key documents
Asset Allocation
Equities94.5 %
Other5.5 %
Data as of:  31 Jan 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 53.4 %
0.0 %
+ 23.3 %
+ 7.3 %
+ 8.5 %
From 19/11/2015
To 20/02/2025
Calendar Year Performance 2024
- 4.1 %
+ 1.1 %
+ 18.9 %
- 18.8 %
+ 24.9 %
+ 43.8 %
- 10.9 %
- 14.8 %
+ 9.2 %
+ 4.8 %
Net Asset Value
153.38 €
Asset Under Management
396 M €
Market
Emerging markets
SFDR - Fund Classification

Article

9
Data as of:  20 Feb 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio Emergents fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Jan 2025.
Fund management team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager

Market environment

  • Emerging markets started the year on a positive note in January, supported by a solid rally in Latin American markets, despite the sell-off in AI names following the DeepSeek news.

  • In China, economic data came in slightly lower in January vs. December for both the NBS manufacturing PMI (49.1 for January vs. 50.1 for December) and the NBS non-manufacturing PMI (50.2 for January vs. 52.2 for December). At the end of the period, Chinese markets were closed for the Lunar New Year.

  • The start of D. Trump's second term as President of the United States brought a wind of uncertainty to the markets. At the end of the period, President Trump announced tariffs of 25% on Mexico and 25% on Canada, as well as additional tariffs of 10% on Chinese goods.

  • Finally, Latin American markets ended the month higher, with the Brazilian market recovering after the strong correction in 2024. In contrast, Indian markets sold off on profit-taking after 3 years of positive performance.

Performance commentary

  • In this context, the fund delivered a positive performance, outperforming its reference indicator.

  • The primary driver of this good performance was Taiwan Semiconductor, the global leader in the foundry industry, which reported a significant increase in fourth-quarter results and continues to benefit from strong demand for its AI chips. Additionally, South Korean company SK Hynix posted good results, further supporting our performance.

  • Despite the disruption in stock prices of companies operating in artificial intelligence due to the DeepSeek announcement, our holdings still ended the month on a positive note.

  • Our Latin American portfolio also contributed positively to the overall performance. Notably, our Brazilian holdings Eletrobras and Equatorial Energia, along with our investment in the Mexican bank Grupo Banorte, boosted the fund's performance.

Outlook strategy

  • After a year in 2024 marked by the underperformance of emerging markets compared to US markets, we remain constructive on Emerging Equities, as we believe that current valuations reflect a pessimistic scenario.

  • We are in the view that the economic decoupling between the US and China will not have the negative consequences expected by the market. China's exports to the US in fact represent no more than 13% of total Chinese exports.

  • On the other hand, Donald Trump's protectionist policies are pushing us to adopt a measured allocation to China, with a slight underweight positioning relative to our reference indicator. Our Chinese portfolio is composed of domestic consumer companies and should therefore not be directed impacted by the potential rise in US tariffs.

  • We are maintaining a significant allocation to India, where the long-term outlook remains promising. However, tight valuations and technical factors – such as the significant capital inflows in recent years – require a more selective approach.

  • We are maintaining a significant exposure to the artificial intelligence theme. Over the month, we continued to strengthen our position in SK Hynix, the world leader in the manufacture of sophisticated HBM (High Bandwidth Memory) memory, which receives 100% of its orders from Nvidia. On the contrary, we reduced our stake in Samsung, which has fallen behind Hynix.

  • After the sharp correction in 2024, we remain constructive on our Latin American portfolio and we are maintaining our positions, particularly in Brazil. Despite the rebound in January, we believe that our Brazilian stocks are attractively valued, and notably our investments in power utility companies.

  • Over the month, we reduced our position in the Argentine bank Galicia on profit taking, after the stock's strong performance since our investment in the last quarter of 2024.

Performance Overview

Data as of:  20 Feb 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.​From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested. The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 23/02/2025

Carmignac Portfolio Emergents Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Jan 2025.
Asia77.4 %
Latin America21.6 %
Eastern Europe1.0 %
Total % Equities100.0 %
Asia77.4 %
cnChina
21.2 %
inIndia
20.3 %
twTaiwan
14.9 %
krSouth Korea
12.9 %
hkHong Kong
3.1 %
myMalaysia
2.6 %
sgSingapore
2.5 %

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  31 Jan 2025.
Equity Investment Weight94.5 %
Net Equity Exposure90.5 %
Number of Equity Issuers37
Active Share81.2 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Managers.
Fund Management Team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager
For over 30 years, Carmignac has been a pioneer in emerging markets. The combination of our fundamental financial analysis and our extra-financial approach, strengthened over the years, enables us to navigate emerging markets through our dedicated strategy.
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager
View Fund's characteristics

Related articles

Emerging equities7 January 2025English

Naomi Waistell to join Carmignac EM equities team

2 minute(s) read
Find out more
Sustainable investing10 July 2024English

Carmignac’s Article 9 funds: a sustainable investment?

3 minute(s) read
Find out more
Emerging equities20 February 2023English

Our Fund Managers awarded for excellence

2 minute(s) read
Find out more
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.